Eli Lilly reported Q3 revenue and earnings that fell short of analysts' expectations. Mounjaro and Zepbound faced challenges as U.S. wholesalers reduced inventories of the drugs. The bull case for ...

Eli Lilly’s Third Quarter Earnings Miss and Forecast Cut Lead to Sharp Stock Drop INDIANAPOLIS (AP) — Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third ...

Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two key drugs that missed expectations INDIANAPOLIS -- Eli Lilly is dialing ...

Lilly shares were off 8%, wiping out nearly $70 billion from the Indianapolis-based drugmaker's market value. Both its weight-loss drug Zepbound and diabetes treatment Mounjaro have been contending ...

(Reuters) -Eli Lilly expects to start selling its weight-loss drug in Hong Kong as early as the end of this year, Bloomberg News reported on Sunday. The drugmaker has received approval from the ...

Moss and Kaliakmanis threw for nearly identical ... Efficiency was the name of the game for USC, which did not stand out in any area compared to Rutgers, but it scored more than double the points.

While it's hard to estimate how much of the eczema market Lilly will be able to acquire, Ebglyss' differentiators should help the company stand out and make a name for itself one way or another.

Woody Marks ran for three touchdowns, Miller Moss had two scoring passes and a touchdown run ... And, yeah, it’s great to close one out, and hopefully we get on a run here in the back half of the ...

Miller Moss Plays Lights Out in Win USC Trojans quarterback Miller Moss had arguably his best overall game of the 2024 season ...

LOS ANGELES (AP) — Woody Marks ran for three touchdowns, Miller Moss had two scoring passes and ... And, yeah, it’s great to close one out, and hopefully we get on a run here in the back ...